Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Acquisition

25 Jun 2008 07:00

RNS Number : 4554X
HydroDec Group plc
25 June 2008
 



 

Not for release, publication or distribution, in whole or in part in, into or from the United States of America or any of its territories, Canada, or Japan, or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

 

 

25th June 2008

 

 

 

RECOMMENDED ACQUISITION

by

Hydrodec Group plc ("Hydrodec")

of

Virotec International plc ("Virotec")

Scheme of Arrangement becomes Effective

 

The scheme of arrangement under sections 895 to 901 of the Companies Act 2006 (the "Scheme") and the claim form to confirm the Reduction under section 137 of the 2006 Act to implement the recommended acquisition by Hydrodec of the entire issued and to be issued share capital of Virotec (other than the Excluded Shares) has now become effective in accordance with the terms of the Scheme and the Acquisition has been completed. 

Under the terms of the Scheme, Virotec Shareholders are entitled to receive 1 New Hydrodec Share for every 3.75 Scheme Shares held in Virotec. 

Dealings in Virotec Shares on AIM have been cancelled at Hydrodec's request, with effect from 7.00am today. 

Settlement of the Cash Consideration in respect of the Virotec Shares will be effected within 14 days of today in accordance with the terms of the Scheme. Application has been made for the admission to trading on AIM of 64,689,227 New Hydrodec Shares. These New Hydrodec Shares, which will rank pari passu in all respects with the existing shares in issue, have been allottedAdmission and Commencement of dealings in the New Hydrodec Shares on AIM is expected to become effective on 25 June 2008.

 

For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 0.5p each of Hydrodec in issue on the date of admission will be 268,718,839 with each share holding one voting right. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Capitalised terms used but not defined in this announcement have the same meanings as set out in the scheme document dated 13 May 2008. 

Enquires:

John Gunn 

Hydrodec Group plc 

+44 (0) 20 7621 5770 

Anthony Richardson 

Nick Westlake 

Numis Securities Limited 

+44 (0) 20 7260 1000 

Emma Davis

Curve Public Relations

+44 (0) 20 8742 1597

Numis Securities Limited, which is regulated in the United Kingdom by the Financial Services Authority, is acting for Hydrodec and no-one else in connection with the Acquisition and will not be responsible to anyone other than Hydrodec for providing the protections afforded to customers of Numis Securities Limited or for providing advice in relation to the Acquisition or any other matter referred to herein. 

 

 

Ludgate Investments Limited, which is regulated in the United Kingdom by the Financial Services Authority, is acting for Hydrodec and no-one else in connection with the Acquisition and will not be responsible to anyone other than Hydrodec for providing the protections afforded to customers of Ludgate Investments Limited or for providing advice in relation to the Acquisition or any other matter referred to herein. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXKLAALPEFE
Date   Source Headline
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSProposed placing to raise a minimum of £10m
28th Sep 20183:45 pmRNSBusiness Review Update
10th Sep 20187:00 amRNSHalf-year Report
22nd Aug 20187:00 amRNSRe-refining technology patent extended to Europe
15th Aug 20183:27 pmRNSHolding(s) in Company
3rd Aug 20187:00 amRNSTrading Update
27th Jun 201812:10 pmRNSResult of AGM
4th Jun 20182:32 pmRNS2017 Annual Report and Accounts and Notice of AGM
31st May 20181:39 pmRNSDirector/PDMR Shareholding
31st May 201812:05 pmRNSFinal Results
25th May 20187:00 amRNSChange of Adviser
2nd May 20187:00 amRNSQ1 Trading Update
4th Apr 20187:00 amRNSDirectorate Change
29th Jan 20187:00 amRNSPre-close Trading Update
28th Dec 20177:00 amRNSExtension of working capital facilities
16th Nov 20172:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20175:16 pmRNSHolding(s) in Company
31st Oct 201711:38 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSGrant of options
26th Oct 20177:00 amRNSQ3 Trading Update
5th Oct 20177:00 amRNSHolding(s) in Company
25th Sep 20177:00 amRNSHalf Yearly Report
18th Sep 20177:00 amRNSNew patent
12th Jul 20177:00 amRNSCarbon Credit Service Agreement
27th Jun 201711:00 amRNSResult of AGM
27th Jun 20177:00 amRNSAGM Statement
2nd Jun 20179:32 amRNS2016 Annual Report and Accounts and Notice of AGM
12th May 20177:00 amRNSFinal Results
8th May 20177:00 amRNSInitial Sale of Carbon Credits
12th Apr 20177:00 amRNSQ1 2017 Trading Update
11th Apr 20174:11 pmRNSHolding(s) in Company
14th Feb 201710:52 amRNSHolding(s) in Company
14th Feb 201710:48 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSPre-close Trading Update
24th Jan 201711:45 amRNSHolding(s) in Company
12th Dec 20167:00 amRNSTrading Update
20th Oct 201611:30 amRNSHolding(s) in Company
17th Oct 20167:00 amRNSAdditional Investment in Hydrodec of North America
11th Oct 201611:20 amRNSHolding(s) in Company
3rd Oct 20161:30 pmRNSChange of Registered Office
16th Sep 20167:00 amRNSHalf Yearly Report
8th Sep 20167:00 amRNSCarbon Credit Project Approval
18th Aug 20167:00 amRNSContract Win
21st Jul 20165:00 pmRNSHolding(s) in Company
20th Jul 20167:00 amRNSTrading Update
24th Jun 20164:58 pmRNSDirector/PDMR Shareholding
14th Jun 201612:50 pmRNSHolding(s) in Company
10th Jun 201612:53 pmRNSDirector's shareholding
9th Jun 20165:35 pmRNSDirectors' shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.